Novel processed form of syndecan-1 shed from SCC-9 cells plays a role in cell migration

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Aragão, Annelize Z B ^a   Belloni, Marília ^a   Simabuco, Fernando M ^a   Zanetti, Mariana R ^a   Yokoo, Sami ^a   Domingues, Romênia R ^a   Kawahara, Rebeca ^a   Pauletti, Bianca A ^a   Gonçalves, Anderson ^a   Agostini, Michelle ^b   Graner, Edgard ^b   Coletta, Ricardo D ^b   Fox, Jay W ^c   Leme, Adriana F Paes ^a  

^a BRAZILIAN CENTER FOR RESEARCH IN ENERGY AND MATERIALS CNPEM   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE; SYNDECAN 1;

ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; HUMAN; HUMAN CELL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN SECRETION; PROTEIN SHEDDING; TUMOR CELL LINE; TUMOR PROMOTION;

CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CHROMATOGRAPHY, LIQUID; CULTURE MEDIA, CONDITIONED; GELATINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MASS SPECTROMETRY; PEPTIDES; PROTEOMICS; SYNDECAN-1; TANDEM MASS SPECTROMETRY; TIME FACTORS; WOUND HEALING;

EID: 84865054658     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043521     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer Statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Jacobs JM, Waters KM, Kathmann LE, Camp II DG, Wiley HS, et al. (2008) The mammary epithelial cell secretome and its regulation by signal transduction pathways. J Proteome Res 2: 558-569.
3. Faça VM, Ventura AP, Fitzgibbon MP, Pereira-Faça SR, Pitteri SJ, et al. (2008) Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains. PLoS One 3(6): e2425 Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0002425.
4. Yao L, Zhang Y, Chen K, Hu X, Xu L X (2011) Discovery of IL-18 as a novel secreted protein contributing to doxorubicin resistance by comparative secretome analysis of MCF-7 and MCF/Dox. PLoS One 6:e24684. Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0024684. Accessed 2012 Jul 26.
5. Brou C, Logeat F, Gupta N, Bessia C, LeBail O, et al. (2000) A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell 5: 207-16.
6. Okamoto I, Kawano Y, Murakami D, Sasayama T, Araki N, et al. (2001) Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J Cell Biol 155: 755-62.
7. Hartmann D, de Strooper B, Serneels L, Craessaerts K, Herreman A, et al. (2002) The disintegrin/metalloprotease ADAM 10 is essential for Notch signaling but not for alpha-secretase activity in fibroblasts. Hum Mol Genet 11: 2615-24.
8. Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, et al. (2002) A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J 21: 1948-56.
9. Demidova-Rice TN, Wolf L, Deckenback J, Hamblin MR, Herman IM (2012) Human platelet-rich plasma- and extracellular matrix-derived peptides promote impaired cutaneous wound healing in vivo. PLoS One 7(2): e32146. Available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285658/pdf/pone.0032146.pdf. Accessed 2012 Jul 26.
10. Manon-Jensen T, Itoh Y, Couchman JR, (2010) Proteoglycan in health and disease: the multiple roles of syndecan shedding. FEBS Journal 277: 3876-3889.
11. Zong F, Fthenou E, Mundt F, Szatmáril T, Kovalszky I, et al. (2011) Specific syndecan-1 domains regulate mesenchymal tumor cell adhesion, motility and migration. Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0014816. Accessed 2012 Jul 26.
12. Martínez A, Spencer ML, Brethauer U, Grez P, Marchesani FJ, et al. (2009) Reduction of syndecan-1 expression during lip carcinogenesis. J Oral Pathol Med 38(7): 580-583.
13. Kurokawa H, Zhang M, Matsumoto S, Yamashita Y, Tanaka T, et al. (2006) Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma. J Oral Pathol Med. 35(5): 301-306.
14. Ro Y, Muramatsu T, Shima K, Yajima Y, Shibahara T, et al. (2006) Correlation between reduction of syndecan-1 expression and clinico-pathological parameters in squamous cell carcinoma of tongue. Int J Oral Maxillofac Surg. 35(3): 252-257.
15. Doucet A, Butler GS, Rodríguez D, Prudova A, Overall CM, (2008) Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome. Mol Cell Proteomics 7(10): 1925-1951.
16. Karagiannis GS, Pavlou MP, Diamandis EP, (2010) Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology. Mol Oncol 4 (6): 496-510.
17. Cauwe B, Van den Steen PE, Opdenakker G, (2007) The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 42(3): 113-185.
18. Wu CC, Hsu CW, Chen CD, Yu CJ, Chang KP, et al. (2010) Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol Cell Proteomics 9: 1100-1117.
19. Ramani VC, Pruett PS, Thompson CA, DeLucas LD, Sanderson RD, (2012) Heparan sulfate chains of syndecan-1 regulate ectodomain shedding. J Biol Chem 287: 9952-9961.
20. Martínez A, Spencer ML, Brethauer U, Grez U, Marchesani FJ, et al. (2009) Reduction of syndecan-1 expression during lip carcinogenesis. J Oral Pathology & Medicine 38 (7): 580-583.
21. Kurokawa H, Zhang M, Matsumoto S, Yamashita Y, Tanaka T, et al. (2006) Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma. J Oral Pathology & Medicine 35 (5): 301-306.
22. Caescu CI, Jeschke GR, Turk BE, (2010) Active site determinants of substrate recognition by the metalloproteinases TACE and ADAM10. Biochem J 424 (1): 79-88.
23. Endo K, Takino T, Miyamori H Kinsen H, Yoshizaki T, et al. (2003) Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J Biol Chem 278 (42): 40764-40770.
24. Heinz A, Jung M C, Duca L, Sippl W, Taddese S, et al. (2010) Degradation of tropoelastin by matrix metalloproteinases -cleavage site specificities and release of matrikines. FEBS J 277 (8): 1939-1956.
25. Nikolova V, Koo CY, Ibrahim SA, Wang Z, Spillmann D, et al. (2009) Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression. Carcinogenesis. 30(3): 397-407.
26. Yang Y, Yaccoby S, Liu W, Langford JK, Pumphrey CY, et al. (2002) Soluble syndecan-1 promotes growth of myeloma tumors in vivo. Blood. 100(2): 610-617.
27. Chen P, Abacherli LE, Nadler ST, Wang Y, Li Q, et al. (2009) MMP7 Shedding of syndecan-1 facilitates re-epithelialization by affecting α2β1 integrin activation. Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0006565. Accessed 2012 Jul 26.
28. Beauvais DM, Rapraeger AC, (2003) Syndecan-1-mediated cell spreading requires signaling by αvβ3 integrins in human breast carcinoma cells. Exp Cell Res 286 (2): 219-232.
29. McQuade KJ, Beauvais DM, Burbach BJ, Rapraeger AC, (2006) Syndecan-1 regulates αvβ5 integrin activity in B82L fibroblasts. J Cell Sci 119 (12): 2445-2456.
30. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, et al. (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106 (3): 761-771.
31. Berti DA, Morano C, Russo LC, Castro LM, Cunha FM, et al. (2009) Analysis of Intracellular substrates and products of thimet oligopeptidase in human embryonic kidney 293 cells. J Biol Chem 284 (21): 14105-14116.
32. Villén J, Gygi SP, (2008) The SCX/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry. Nat Protocol 3 (10): 1630-1638.
33. Paes Leme AF, Sherman NE, Smalley DM, Sizukusa LO, Oliveira AK, et al. (2012) Hemorrhagic activity of HF3, a snake venom metalloproteinase: insights from the proteomic analysis of mouse skin and blood plasma. J Proteome Res 11(1): 279-291.
34. Escalante T, Rucavado A, Pinto AFM, Terra RMS, Gutirrez JM, et al. (2009) Wound exudate as a proteomic window to reveal different mechanisms of tissue damage by snake venom toxins. J Proteome Res 8 (11): 5120-5131.
35. Eming SA, Koch M, Krieger A, Brachvogel B, Kreft S, et al. (2010) Differential proteomic analysis distinguishes tissue repair biomarker signatures in wound exudates obtained from normal healing and chronic wounds. J Proteome Res 9 (9): 4758-4766.
36. Liu H, Sadygov RG, Yates JR III, (2004) a model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 76 (14): 4193-4201.
37. Liang CC, Park AY, Guan JL, (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protocol 2(2): 329-33.
38. Humphries MJ (2001) Cell-Substrate Adhesion Assays. Current Protocols in Cell Biology. 2001 John Wiley & Sons, Inc. DOI 10.1002/0471143030.cb0901s00.
39. Paes Leme AF, Kitano E, Furtado MF, Valente R, Camargo ACM, et al. (2009) Analysis of the subproteomes of proteinases and heparin-binding toxins of eight bothrops venoms. Proteomics 9: 733-745.